Onychomycosis: Modern diagnostic and treatment approaches

Wiener Medizinische Wochenschrift

Volumn 163, Issue 1-2, 2013, Pages 1-12

  Tchernev, Georgi ^a   Penev, Plamen Kolev ^b   Nenoff, Pietro ^c   Zisova, Liliya Georgieva ^d   Cardoso, José Carlos ^e   Taneva, Teodora ^a   Ginter Hanselmayer, Gabriele ^f   Ananiev, Julian ^b   Gulubova, Maya ^b   Hristova, Reni ^d   Nocheva, Desislava ^d   Guarneri, Claudio ^g   Martino, G ^g   Kanazawa, Nobuo ^h  

^a UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

^b TRAKIA UNIVERSITY   (Bulgaria)

^c Haut und Laborarzt Allergologie Andrologie Labor für Medizinische Mikrobiologie Partnerschaft Prof Dr Med Pietro Nenoff and Dr Med Constanze Krüger   (Germany)

^d MEDICAL UNIVERSITY OF PLOVDIV   (Bulgaria)

^e CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^f MEDICAL UNIVERSITY OF GRAZ   (Austria)

^g UNIVERSITY OF MESSINA   (Italy)

^h WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Antifungal therapy; Itraconazole; Laser treatment; MALDI TOF MS; Onychomycosis; Terbinafine; Trichophyton rubrum; Uniplex PCR ELISA Test

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; AMOROLFINE; CICLOPIROX; CICLOPIROXOLAMINE; FLUCONAZOLE; FUNGAL DNA; ITRACONAZOLE; NAFTIFINE; POLINAIL; TERBINAFINE; UNCLASSIFIED DRUG;

CANDIDA; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CHRONIC VEIN INSUFFICIENCY; DERMATOLOGIST; DERMATOPHYTE; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DRUG PULSE THERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMOPHYTON FLOCCOSUM; FALSE NEGATIVE RESULT; FLUORESCENCE MICROSCOPY; FUNGAL DETECTION; FUNGUS CULTURE; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; LABORATORY DIAGNOSIS; LOW LEVEL LASER THERAPY; MALASSEZIA; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDICAL SPECIALIST; MICROBIAL IDENTIFICATION; MICROSCOPY; MOLECULAR BIOLOGY; MOULD; MULTIPLE CYCLE TREATMENT; NEODYMIUM YAG LASER; ONYCHOMYCOSIS; PATHOGENESIS; PERIPHERAL VASCULAR DISEASE; PHOTODYNAMIC THERAPY; POLYMERASE CHAIN REACTION; POLYNEUROPATHY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; STANDARDIZATION; SWEATING; SYSTEMIC THERAPY; TREATMENT DURATION; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM; TRICHOPHYTON TONSURANS; YEAST;

ANTIFUNGAL AGENTS; CANDIDIASIS; COMBINED MODALITY THERAPY; DERMATOMYCOSES; DNA, FUNGAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUCONAZOLE; HUMANS; ITRACONAZOLE; LASER THERAPY, LOW-LEVEL; LASERS, SOLID-STATE; NAPHTHALENES; ONYCHOMYCOSIS; OPPORTUNISTIC INFECTIONS; POLYMERASE CHAIN REACTION; RISK FACTORS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TINEA;

EID: 84873743178     PISSN: 00435341     EISSN: 1563258X     Source Type: Journal    
DOI: 10.1007/s10354-012-0139-3     Document Type: Review

References (63)

1. Gupta AK, Jain HC, Lynde CW. Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: a multicenter Canadian survey of 15,000 patients. J Am Acad Dermatol. 2000;43:244-8.
2. Ghannoum MA, Hajjeh RA, Scher R, Konnikov N, Gupta AK, Summerbell R et al. A large scale North American study of fungal isolated from nails; the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. J Am Acad Dermatol. 2000;43:641-8.
3. Hamnerius N, Berglund J, Faergemann J. Pedal dermatophyte infection in psoriasis. Br J Dermatol. 2004;150:1125-8.
4. Burzykowski T, Molenberghs G, Abeck D, et al. High prevalence of foot disease in Europe; results of the Ahilese project. Mycoses. 2003;46:496-505.
5. Wolff K, Johnson RA, Suurmond D. Fitzpatrick's color atlas and synopsis of clinical dermatology. 5th ed. New York: McGraw Hill; 2005. p. 1004.
6. Shemer A, Nathansohn N, Kaplan B, Trau H. Toenail abnormalities and onychomycosis in chronic venous insufficiency of the legs: should we treat? J Eur Acad Dermatol Venereol. 2008;22:279-82.
7. Gupta AK, Gupta MA, Summerbell RC, et al. The epidemiology of onychomycosis: possible role of smoking and peripheral arterial disease. J Eur Acad Dermatol Venereol. 2000;14:466-9.
8. Ginter-Hanselmayer G, Weger W, Smolle J. Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients. J Eur Acad Dermatol Venereol. 2008;22:470-5.
9. Zisova L, Valtchev V, Sotiriou E, Gospodinov D, Mateev G. Enychomycosis in patients with psoriasis - a multicenter study. Mycoses. 2011;55(2):143-7.
10. Leibovici V, Heirshko K, Ingber A, Westerman M, Leviatan-Strauss N, Hoshberg M. Increased prevalence of onychomycosis among psoriatic patients in Israel. Acta Derm Venereol. 2008;88:31-3.
11. Gupta AK, Lynde CW, Jain HC, et al. A higher prevalence of onychomycosis in psoriatics compared with non-psoriatics: a multicenter study. Br J Dermatol. 1997;136:786-9.
12. Bristow IR, Spruce MC. Fungal foot infection, cellulitis and diabetes: a review. Diabet Med. 2009;26:548-51.
13. Fletcher CL, Hay RJ, Smeeton NC. Observer agreement in recording the clinical signs of nail disease and the accuracy of a clinical diagnosis of fungal and non-fungal nail disease. Br J Dermatol. 2003;148:558-62.
14. Zaias N, Tosti A, Rebell G, et al. Autosomal dominant pattern of distal subungual onychomycosis caused by Trichophyton rubrum. J Am Acad Dermatol. 1996;34:302-4.
15. Svejgaard EL, Nilsson J. Onychomycosis in Denmark: prevalence of fungal nail infection in general practice. Mycoses. 2004;47:131-5.
16. Roujeau JC, Sigurgeirsson B, Korting HC, Kerl H, Paul C. Chronic dermatomycoses of the foot as risk factors for acute bacterial cellulitis of the leg: a case-control study. Dermatology. 2004;209:301-7.
17. Tchernev G, Cardoso JC, Ali MM, Patterson JW. Primary onychomycosis with granulomatous Tinea faciei. Braz J Infect Dis. 2010;14:546-7.
18. Nenoff P, Mügge C, Herrmann J, Keller U. Tinea faciei incognito due to Trichophyton rubrum as a result of autoinoculation from onychomycosis. Mycoses. 2007;50 Suppl 2:20-5.
19. Nenoff P, Wetzig T, Gebauer S, et al. Tinea barbae et faciei durch Trichophyton rubrum. Akt Dermatol. 1999;25:392-6.
20. Szepietowski JC, Reich A. Stigmatisation in onychomycosis patients: a population-based study. Eœycoses. 2009;52:343-9.
21. Effendy I, Lecha M, Feuilhade de Chauvin M, Di Chiacchio N, Baran R. European onychomycosis observatory. Epidemiology and clinical classification of onychomycosis. J Eur Acad Dermatol Venereol. 2005;19 Suppl 1:8-12.
22. Guibal F, Baran R, Duhard E, Feuilhade de Chauvin M. Epidemiology and management of onychomycosis in private dermatological practice in France. Ann Dermatol Venereol. 2008;135:561-6.
23. Shemer A, Trau H, Davidovici B, Grunwald MH, Amichai B. Nail sampling in onychomycosis: comparative study of curettage from three sites of the infected nail. J Dtsch Dermatol Ges. 2007;5:1108-11.
24. Nenoff P, Ginter-Hanselmayer G, Tietz HJ. Fungal nail infections - an update: part 2 - from the causative agent to diagnosis - conventional and molecular procedures. Hautarzt. 2012;63:130-8.
25. Weinberg JM, Koestenblatt EK, Tutrone WD, Tishler HR, Najarian L. Comparison of diagnostic methods in the evaluation of onychomycosis. J Am Acad Dermatol 2003;49:193-7.
26. Nenoff P, Ginter-Hanselmayer G, Tietz HJ. Fungal nail infections - an update: part 1 - prevalence, epidemiology, predisposing conditions, and differential diagnosis. Hautarzt. 2012;63:30-8.
27. El Fari M, Tietz H-J, Presber W, Sterry W, Gräser Y. Development of an oligonucleotide probe specific for Trichophyton rubrum. Br J Dermatol. 1999;141:240-5.
28. Mügge C, Haustein UF, Nenoff P. Causative agents of onychomycosis - a retrospective study. J Dtsch Dermatol Ges. 2006;4:218-28.
29. Gräser Y, Scott J, Summerbell RC. The new species concept in dermatophytes - a polyphasic approach. Mycopathologia. 2008;166:239-56.
30. Heidemann S, Monod M, Gräser Y. Signature polymorphisms in the internal transcribed spacer region relevant for the differentiation of zoophilic and anthropophilic strains of Trichophyton interdigitale and other species of T. mentagrophytes sensu lato. Br J Dermatol. 2010;162:282-95.
31. Nenoff P, Mügge E¡, Haustein UF. Differenzierung der klinisch wichtigsten Dermatophyten. Teil I: Trichophyton. Derm Prakt Dermatol. 2002;8:16-31.
32. Beifuss B, Bezold G, Gottlöber P, et al. Direct detection of five common dermatophyte species in clinical samples using a rapid and sensitive 24-h PCR-ELISA technique open to protocol transfer. Mycoses. 2011;54:137-45.
33. Brillowska-Dabrowska A, Saunte DM, Arendrup MC. Five-hour diagnosis of dermatophyte nail infections with specific detection of Trichophyton rubrum. J Clin Microbiol. 2007;45:1200-4.
34. Nenoff P, Herrmann J, Gräser Y. Trichophyton mentagrophytes sive interdigitale? Ein dermatophyt im wandel der zeit. J Dtsch Dermatol Ges. 2007;5:198-203.
35. Kallow W, Erhard M, Shah H, Raptakis E, Welker M. Chapter 12 - MALDI-TOF MS for microbial identification: years of experimental development to an established protocol. In: Shah H, Gharbia S, Encheva V, editors. Mass spectrometry for microbial proteomics. Chichester:Wiley; 2010. pp. 255-76. ISBN:978-0-470-68199-2.
36. Stackebrandt E, Päuker E, Erhard Eœ. Grouping myxococci (Corallococcus) strains by matrix-assisted laser desorption Ionization time-of-flight (MALDI TOF) mass spectrometry: comparison with gene sequence phylogenies. Curr Microbiol. 2005;50:71-7.
37. Donohue MJ, Smallwood EW, Pfaller S, Rodgers M, Shoemaker JA. The development of a matrix-assisted laser desorption/ionization mass spectrometry-based method for the protein fingerprinting and identification of Aeromonas species using whole cells. J Microbiol Methods. 2006;65:380-9.
38. Donohue MJ, Best JM, Smallwood AW, Kostich M, Rodgers M, Shoemaker JA. Differentiation of Aeromonas isolated from drinking water distribution systems using matrix-assisted laser desorption/ionization-mass spectrometry. Anal Chem. 2007;79:1939-46.
39. Pignone M, Greth KM, Cooper J, Emerson D, Tang J. Identification of mycobacteria by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry. J Clin Microbiol. 2006;44:1963-70.
40. Erhard M, Hipler UC. SARAMIS-MALDI-TOF MS analysis of Aspergillus species. Mycoses. 2007;50:352 (abstract).
41. Pföhler C, Hollemeyer K, Heinzle E, Altmeyer W, Graeber S, Müller CS, Stark A, Jager SU, Tilgen W. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: a new tool in diagnostic investigation of nail disorders? Exp Dermatol. 2009;18:880-2.
42. Lecha M, Effendy I, Feuilhade de Chauvin M, Di Chiacchio N, Baran R. Taskforce on onychomycosis education. Treatment options-development of consensus guidelines. J Eur Acad Dermatol Venereol. 2005;19 Suppl 1:25-33.
43. Nenoff P. Mykologie - state of the art. Kompendium Dermatol. 2010;6(1):1-3.
44. Gupta AK, Lynch LE, Kogan N, Cooper EA. The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis. J Eur Acad Dermatol Venereol. 2009;23:256-62
45. Zisova L. Fluconazole in the treatment of onychomycosis. Folia Medica. 2004;46:47-50.
46. Gupta AK, Drummond-Main C, Cooper EA, Brintnell W, Piraccini BM, Tosti A. Systematic review of nondermatophyte mold onychomycosis: diagnosis, clinical types, epidemiology, and treatment. J Am Acad Dermatol. 2012;66:494-502.
47. Ling MR, Swinyer LJ, Jarrat MT, et al. Once weekly fluconazole (450 mg) for 4, 6 or 9 months of treatment for distal subungual onychomycosis of the toe nail. J Am Acad Dermotol. 1998;38(6 Pt 2):S95-102.
48. Baran R, Hay RJ. Partial surgical avulsion of the nail in onychomycosis. Clin Exp Dermatol. 1985;10:413-8.
49. Lai WY, Tang WY, Loo SK, Chan Y. Clinical characteristics and treatment outcomes of patients undergoing nail avulsion surgery for dystrophic nails. Hong Kong Med J. 2011;17:127-31.
50. Hochman LG. Laser treatment of onychomycosis using a novel 0.65-millisecond pulsed Nd:YAG 1064-nm laser. J Cosmet Las Ther. 2011;13:2-5.
51. Landsman AS, Robbins AH, Angelini PF, et al. Treatment of mild, moderate, and severe onychomycosis using 870- and 930 nm light exposure. J Am Podiatr Med Assoc. 2010;100:166-77.
52. Manevitch Z, Lev D, Hochberg M, Palhan M, Lewis A, Enk CD. Direct antifungal effect of femtosecond laser on Trichophyton rubrum onychomycosis. Photochem Photobiol. 2010;86:476-9.
53. 2 laser fenestration improves treatment of onychomycosis. Clin Laser Mon. 1992;10:123-4.
54. Rothermel E, Apfelberg DB. Carbon dioxide laser use for certain diseases of the toenails. Clin Podiatr Med Surg. 1987;4:809-21.
55. Hohenleutner U. Innovations in dermatologic laser therapy. Hautarzt. 2010;61:410-5.
56. Aspiroz C, Fortuño Cebamanos B, Rezusta A, Paz-Cristóbal P, Domínguez-Luzón F, Gené Díaz J, Gilaberte Y. Photodynamic therapy for onychomycosis. Case report and review of the literature. Rev Iberoam Micol. 2011;28:191-3.
57. Kamp H, Tietz HJ, Lutz M, Piazena H, Sowyrda P, Lademann J, Blume-Peytavi U. Antifungal effect of 5-aminolevulinic acid PDT in Trichophyton rubrum. Mycoses. 2005;48:101-7.
58. Gilaberte Y, Aspiroz C, Martes MP, Alcalde V, Espinel-Ingroff A, Rezusta A. Treatment of refractory fingernail onychomycosis caused by nondermatophyte molds with methylaminolevulinate photodynamic therapy. J Am Acad Dermatol. 2011;65:669-71.
59. Watanabe D, Kawamura C, Masuda Y, Akita Y, Tamada Y, Matsumoto Y. Successful treatment of toenail onychomycosis with photodynamic therapy. Arch Dermatol. 2008;144:19-21.
60. Sotiriou E, Koussidou-Eremonti T, Chaidemenos G, Apalla Z, Ioannides D. Photodynamic therapy for distal and lateral subungual toenail onychomycosis caused by trichophyton rubrum: preliminary results of a single-centre open trial. Acta Derm Venereol. 2010;90:216-7.
61. Petranyi G, Ryder NS, Stutz A. Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase. Science. 1984;224:1239-41.
62. Ryder NS, Favre B. Antifungal activity and mechanism of action of terbinafine. Rev Contemp Pharmacother. 1997;8:275-87.
63. Ryder NS, Wagner S, Leitner I. In vitro activities of terbinafine against cutaneous isolates of Candida albicans and other pathogenic yeasts. Antimicrob Agents Chemother. 1998;42:1057-61.